Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Jusang Kim 1 Article
A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data
Hyungmin Lee, Jusang Kim
Osong Public Health Res Perspect. 2014;5(Suppl):S8-S17.   Published online December 31, 2014
DOI: https://doi.org/10.1016/j.phrp.2014.11.001
  • 1,900 View
  • 20 Download
  • 10 Citations
AbstractAbstract PDF
Objectives
From the perspective of public health, tuberculosis (TB) remains an important issue that threatens health. Korea is an intermediate burden country with a TB incidence of 97/100,000 individuals. Among many TB control measures, a relapse rate of TB is one indicator that can be used to indirectly assess the level of TB control in countries and in communities. Relapse TB has an approximately 12% yearly incidence in Korea. This study aims to estimate the relapse rate of TB and to investigate the associated factors by using nationwide TB notification data in Korea.
Methods
The nationwide TB notification data in 2005 was used with the exclusion criteria of duplicated reporting, foreign-born patients, outcome–died, and outcome–diagnosis changed. The data were double-checked as to whether they were reported again during 2006–2010 and the estimated relapse rate of TB. Associated factors were analyzed by multivariate logistic regression with the variables of age, sex, registration type, results of sputum smear test, medication, and outcome of treatment.
Results
Among 45,434 TB patients in 2005, 4,371 patients were again reported as TB patients from 2006 to 2010. Five hundred and sixty-four patients were reported more than twice and the cumulative number of relapses was 5,072 cases. The 5-year relapse rate was estimated as 9.62%. The relapse rate decreased yearly: 4.8% in 2006, 2.4% in 2007, 1.6% in 2008, 1.4% in 2009, and 1.0% in 2010. Age, sex, registration type, tuberculosis type, and medication were independently associated with a relapse of TB. In the multivariate logistic regression analysis, the following factors were related: male sex, 40–49 years old; registration type, relapse, treatment after failure, treatment after default, transfer in, and other, the sputum smear-positive pulmonary TB, and medications (including individuals taking 2–5 drugs).
Conclusion
This study has estimated a 5-year relapse rate of TB in Korea that is slightly lower than the rate of relapse TB in the annual reports. This study could be conducted and cross-checked with data from the National Health Insurance in the future.

Citations

Citations to this article as recorded by  
  • Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study
    Hin Moi Youn, Moon-Kyung Shin, Dawoon Jeong, Hee-Jin Kim, Hongjo Choi, Young Ae Kang, Jun Hyeok Lim
    PLOS ONE.2022; 17(6): e0268290.     CrossRef
  • Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model
    Hyunwoo Cho, Youngmok Park, Jeongjoo Seok, Joon Sup Yeom, Jun Yong Choi, Hee Jin Kim, Young Ae Kang, Jeehyun Lee
    BMJ Global Health.2021; 6(10): e005953.     CrossRef
  • Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
    Johan Vekemans, Michael James Brennan, Mark Hatherill, Lewis Schrager, Bernard Fritzell, Kathryn Rutkowski, Beatrice De Vos, Matteo Zignol, Georges Thiry, Ann M. Ginsberg, Barry Walker
    Vaccine.2020; 38(2): 135.     CrossRef
  • Rate and risk factors of recurrent tuberculosis in Yemen: a 5-year prospective study
    Mohammed Saif Anaam, Alian A. Alrasheedy, Saud Alsahali, Saeed O. Alfadly, Adel H. Aldhubhani
    Infectious Diseases.2020; 52(3): 161.     CrossRef
  • Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection
    Matthew B. Huante, Tais B. Saito, Rebecca J. Nusbaum, Kubra F. Naqvi, Sadhana Chauhan, Robert L. Hunter, Jeffrey K. Actor, Jai S. Rudra, Mark A. Endsley, Joshua G. Lisinicchia, Benjamin B. Gelman, Janice J. Endsley
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis
    Benjawan Kaewseekhao, Sittiruk Roytrakul, Yodying Yingchutrakul, Kanin Salao, Wipa Reechaipichitkul, Kiatichai Faksri, HASNAIN SEYED EHTESHAM
    PLOS ONE.2020; 15(4): e0231834.     CrossRef
  • The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study
    Hyun Jin Song, Haesuk Park, Susan Park, Jin-Won Kwon
    Pharmacoepidemiology and Drug Safety.2019; 28(6): 830.     CrossRef
  • Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing
    Laila Parvaresh, Taryn Crighton, Elena Martinez, Andrea Bustamante, Sharon Chen, Vitali Sintchenko
    BMC Infectious Diseases.2018;[Epub]     CrossRef
  • Treatment Outcomes of Patients Treated for Pulmonary Tuberculosis after Undergoing Gastrectomy
    In Young Jung, Moo Hyun Kim, Woo Yong Jeong, Mi Young Ahn, Yong Duk Jeon, Hea Won Ahn, Jin Young Ahn, Je Eun Song, Dong Hyun Oh, Yong Chan Kim, Eun Jin Kim, Su Jin Jeong, Nam Su Ku, June Myung Kim, Jun Yong Choi
    The Tohoku Journal of Experimental Medicine.2016; 240(4): 281.     CrossRef
  • Is Tuberculosis Still the Number One Infectious Disease in Korea?
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2014; 5: S1.     CrossRef

PHRP : Osong Public Health and Research Perspectives